Certara

Yahoo Finance • last month

Certara Simcyp® Simulator Results Replace Ten Human Trials for Chronic Myeloid Leukemia (CML) Therapy asciminib

Certara Biosimulation results highlight how model-informed approaches for drug development and regulatory decision-making save time and money. RADNOR, Pa., March 03, 2026 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader... Full story

Yahoo Finance • 2 months ago

Certara Q4 Earnings Call Highlights

Certara logo 3 Momentum Stocks That Could Soar Post-Market Volatility Certara (NASDAQ:CERT) executives used the company’s fourth-quarter 2025 earnings call to outline a leadership transition, discuss end-market and execution factors that... Full story

Yahoo Finance • 2 months ago

Here are the major earnings before the open Thursday

Major earnings expected before the bell on Thursday include: * Viatris (VTRS [https://seekingalpha.com/symbol/VTRS]) * Baidu (BIDU [https://seekingalpha.com/symbol/BIDU]) * Vistance Networks (VISN [https://seekingalpha.com/symbol/VI... Full story

Yahoo Finance • 4 months ago

Certara (CERT) Valuation Check as New CEO Jon Resnick Takes Over and Outlook Is Reaffirmed

Certara (CERT) just announced a leadership handoff that investors cannot ignore, naming longtime IQVIA executive Jon Resnick as its next CEO and Board member while reaffirming its 2025 financial outlook. See our latest analysis for Certar... Full story

Yahoo Finance • 4 months ago

Certara Appoints Jon Resnick as Chief Executive Officer

Resnick brings decades of leadership experience in health sciences, business operations, strategy, innovation and commercial growth William Feehery to step down as CEO on December 31, 2025 Company reaffirms full year 2025 financial outlo... Full story

Yahoo Finance • 5 months ago

Cerrado Gold Announces Third Quarter 2025 Financial Results

Gold equivalent production of 13,832 Gold Equivalent Ounces (“GEO”) at AISC of $1,915/oz during Q3 2025Adjusted EBITDA of $11.8 million for Q3 2025Cash $16.5 million Partial hedge expires end December increasing future gold sale pricesFull... Full story

Yahoo Finance • 5 months ago

Certara Reports Third Quarter 2025 Financial Results

RADNOR, Pa., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today reported its financial results for the third quarter of fiscal year 2025. Third Quarter Highlights:... Full story

Yahoo Finance • 6 months ago

Certara Expands Biosimulation Market with AI-Driven QSP Platform

RADNOR, Pa., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced the launch of Certara IQ, a scalable, AI-powered Quantitative Systems Pharmacology (QSP) sol... Full story

Yahoo Finance • 6 months ago

Cerrado Gold Announces Resignation of a Director

TORONTO, Oct. 10, 2025 (GLOBE NEWSWIRE) -- Cerrado Gold Inc. [TSX.V:CERT][OTCQX:CRDOF; FRA:BAI0] (“Cerrado” or the “Company”) announces the resignation of Mr. Robert Campbell from its board of directors effective today. Mr. Campbell has... Full story

Yahoo Finance • 6 months ago

Certara to Report Third Quarter 2025 Financial Results on November 6th, 2025

RADNOR, Pa., Oct. 10, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that it will release financial results for the third quarter of 2025 after the market close on Thursday, Novem... Full story

Yahoo Finance • 6 months ago

Cerrado Gold Announces Acceleration of Exploration Program at Its Minera Don Nicolas Gold Mine

Adding three new drill rigs to accelerate and expand the exploration program following positive initial findingsExploration budget to be increased materiallyMDN will certify its on-site Laboratory for immediate turn around of assay results... Full story

Yahoo Finance • 7 months ago

Certara Launches Pinnacle 21® Enterprise Plus to Deliver Regulatory Submissions Faster

RADNOR, Pa., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the availability of Pinnacle 21 Enterprise Plus. The solution enables clinical and statistical programmers to... Full story

Yahoo Finance • 7 months ago

Cerrado Gold Receives US$8.75M Payment from Hochschild

US$8.75m received from Hochschild Mining Plc. (“Hochschild”) as a prepayment of the US$10m obligation due July 2026Funds strengthen balance sheet, support acceleration of growth initiatives TORONTO, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Ce... Full story

Yahoo Finance • 7 months ago

Certara to Participate in Upcoming Investor Conferences

RADNOR, Pa., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced that Company management will participate in the following investor conferences: Baird Glob... Full story

Yahoo Finance • 8 months ago

Biosimulation Market to Attain USD 18.97 Billion by 2034, Rising at 16.9% CAGR

Ottawa, Aug. 18, 2025 (GLOBE NEWSWIRE) -- The global biosimulation market was valued at USD 3.97 billion in 2024 and is projected to reach approximately USD 18.97 billion by 2034, expanding at a CAGR of 16.9%, according to a study publis... Full story

Yahoo Finance • 8 months ago

Plant Biotechnology Company Evaluation Report 2025 | Bayer, Syngenta, and BASF Lead with Advanced Crop Protection, Seeds, and Sustainable Farming Solutions

Dublin, Aug. 14, 2025 (GLOBE NEWSWIRE) -- The "Plant Biotechnology - Company Evaluation Report, 2025" report has been added to ResearchAndMarkets.com's offering. The Plant Biotechnology Companies Quadrant is a comprehensive industry... Full story

Yahoo Finance • 8 months ago

Certara’s SWOT analysis: biosimulation firm’s stock faces growth hurdles

Certara, Inc. (NASDAQ:CERT), a leading provider of biosimulation software and technology services for drug discovery and development, has been navigating a complex market landscape in 2025. Trading at $11.20, with a market capitalization o... Full story

Yahoo Finance • 8 months ago

Leerink Partners lowers Certara stock price target to $11.50 on valuation concerns

Investing.com - Leerink Partners has reduced its price target on Certara Inc . (NASDAQ:CERT) to $11.50 from $13.00 while maintaining an Outperform rating on the stock. The company’s shares currently trade at $11.13, with analyst targets r... Full story

Yahoo Finance • 8 months ago

Certara signals full year 8–10% revenue growth outlook as AI and QSP momentum builds

Earnings Call Insights: Certara, Inc. (CERT) Q2 2025 MANAGEMENT VIEW * William F. Feehery, CEO, stated that "Certara's second quarter performance reflected continued strength across the organization as we achieved results that were con... Full story

Yahoo Finance • 8 months ago

Certara Appoints Dr. Chris Bouton as Chief Technology Officer to Advance AI in-silico Drug Discovery and Development Platform

RADNOR, Pa., July 31, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced the appointment of Christopher Bouton, Ph.D., as Chief Technology Officer. In this role, Bou... Full story